Attached files
| file | filename |
|---|---|
| EX-10.2 - EX-10.2 - ARIAD PHARMACEUTICALS INC | d796920dex102.htm |
| EX-31.2 - EX-31.2 - ARIAD PHARMACEUTICALS INC | d796920dex312.htm |
| EX-31.1 - EX-31.1 - ARIAD PHARMACEUTICALS INC | d796920dex311.htm |
| EX-10.1 - EX-10.1 - ARIAD PHARMACEUTICALS INC | d796920dex101.htm |
| EX-10.3 - EX-10.3 - ARIAD PHARMACEUTICALS INC | d796920dex103.htm |
| EX-10.4 - EX-10.4 - ARIAD PHARMACEUTICALS INC | d796920dex104.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INC | Financial_Report.xls |
| 10-Q - FORM 10-Q - ARIAD PHARMACEUTICALS INC | d796920d10q.htm |
Exhibit 32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ARIAD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the period ended September 30, 2014 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: November 7, 2014 | /s/ Harvey J. Berger, M.D | |||
| Harvey J. Berger, M.D. | ||||
| Chairman and Chief Executive Officer | ||||
| Date: November 7, 2014 | /s/ Edward M. Fitzgerald | |||
| Edward M. Fitzgerald | ||||
| Executive Vice President, Chief Financial Officer | ||||